Specialty medications are not only used to treat complex conditions, they are themselves complex in nature. Some have...
Read MoreOn August 16th, 2022, President Biden signed into law H.R. 5376, a budget reconciliation measure known as the Inflation...
Read MoreAccording to the Centers for Disease Control and Prevention (CDC), there were as many as 14,000 flu-related deaths and...
Read MoreDigital therapeutics (DTx) uses software programs to prevent, manage or treat diseases. They may be used with or...
Read MoreSpecialty medications continue to be a large source of drug spend, in particular biologic drugs. Biosimilars pose an...
Read MoreCystic fibrosis (CF) is a rare genetic disorder that affects one in 3,900 live births. There are approximately 30,000...
Read MoreOn June 7, 2022, the Centers for Medicare and Medicaid Services (CMS) released the 2021 Part C and Part D Program Audit...
Read MoreElixir announced the launch of a specialty generic medication enhancement to our suite of solutions effective June 1,...
Read MoreWith the growing specialty drug pipeline that is contributing to nearly half of overall drug spend, we have been...
Read MoreThe role of the Clinical Account Executive (CAE) at Elixir is a very important one for helping clients identify...
Read More